Free Trial
NYSE:NSPR

InspireMD (NSPR) Stock Price, News & Analysis

InspireMD logo
$2.39 -0.02 (-0.83%)
Closing price 03:48 PM Eastern
Extended Trading
$2.34 -0.06 (-2.30%)
As of 06:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About InspireMD Stock (NYSE:NSPR)

Key Stats

Today's Range
$2.37
$2.45
50-Day Range
$2.19
$2.60
52-Week Range
$1.99
$3.80
Volume
58,761 shs
Average Volume
69,882 shs
Market Capitalization
$73.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.50
Consensus Rating
Buy

Company Overview

InspireMD Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
58th Percentile Overall Score

NSPR MarketRank™: 

InspireMD scored higher than 58% of companies evaluated by MarketBeat, and ranked 461st out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    InspireMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    InspireMD has only been the subject of 1 research reports in the past 90 days.

  • Read more about InspireMD's stock forecast and price target.
  • Earnings Growth

    Earnings for InspireMD are expected to grow in the coming year, from ($0.79) to ($0.73) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of InspireMD is -3.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of InspireMD is -3.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    InspireMD has a P/B Ratio of 1.31. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.75% of the float of InspireMD has been sold short.
  • Short Interest Ratio / Days to Cover

    InspireMD has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InspireMD has recently increased by 63.87%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    InspireMD does not currently pay a dividend.

  • Dividend Growth

    InspireMD does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.75% of the float of InspireMD has been sold short.
  • Short Interest Ratio / Days to Cover

    InspireMD has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InspireMD has recently increased by 63.87%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    InspireMD has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • Search Interest

    3 people have searched for NSPR on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, InspireMD insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    34.06% of the stock of InspireMD is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    44.78% of the stock of InspireMD is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about InspireMD's insider trading history.
Receive NSPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InspireMD and its competitors with MarketBeat's FREE daily newsletter.

NSPR Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

NSPR Stock Analysis - Frequently Asked Questions

InspireMD's stock was trading at $2.63 at the start of the year. Since then, NSPR stock has decreased by 9.1% and is now trading at $2.39.

InspireMD, Inc. (NYSE:NSPR) issued its quarterly earnings results on Tuesday, November, 12th. The company reported ($0.16) earnings per share for the quarter, beating analysts' consensus estimates of ($0.20) by $0.04. The firm earned $1.81 million during the quarter, compared to the consensus estimate of $1.74 million. InspireMD had a negative trailing twelve-month return on equity of 69.42% and a negative net margin of 413.96%.

InspireMD's top institutional shareholders include Vestia Personal Wealth Advisors (0.06%). Insiders that own company stock include Gary S Roubin and Paul Stuka.
View institutional ownership trends
.

Shares of NSPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that InspireMD investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), Disc Medicine (IRON), Jabil (JBL), Adobe (ADBE) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
11/12/2024
Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NYSE:NSPR
CIK
1433607
Fax
N/A
Employees
50
Year Founded
N/A

Price Target and Rating

High Price Target
$5.00
Low Price Target
$4.00
Potential Upside/Downside
+88.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.79)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$19.92 million
Net Margins
-413.96%
Pretax Margin
-413.00%
Return on Equity
-69.42%
Return on Assets
-57.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.39
Quick Ratio
6.05

Sales & Book Value

Annual Sales
$7.03 million
Price / Sales
10.42
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.83 per share
Price / Book
1.31

Miscellaneous

Outstanding Shares
30,635,000
Free Float
18,332,000
Market Cap
$73.22 million
Optionable
Optionable
Beta
0.57
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NYSE:NSPR) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners